Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psoriasis transplant model study of therapeutic compounds
NL-OMON42470Active, not recruiting
- Sponsor
- Galderma
- Start
- Jan 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in psoriasis, sponsored by Galderma. Primary endpoint: Transplant epidermal thickness. Started Jan 2016; status: active, not recruiting.
02
Conditions
psoriasis
Beyond the preview
Go deeper on NL-OMON42470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42470.